Oncolytics Biotech ONCY Balance Sheet (2009-2026)

NASDAQ ONCY
$0.51 +0.01 (+2.57%)
At close: Oct 21, 2026 · 4:00 PM EDT
Reported Financials

Oncolytics Biotech Quarterly Balance Sheet

Periods 69 quarters
Latest Jun 2026

Oncolytics Biotech reported total assets of $7.67M and total liabilities of $13.84M for the quarter ended Jun 2026, down 44.3% year over year. This balance sheet covers 69 quarters of results from Mar 2009 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Balance SheetBalance Sheet Mar2009 Jun2009 Sep2009 Dec2009 Mar2010 Jun2010 Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Jun2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv.
40.98M37.70M32.38M31.63M26.15M23.67M8.61M11.74M13.22M29.64M26.39M21.87M18.14M14.51M11.11M10.69M10.69M8.88M5.20M4.12M
Short-term InvestmentsInvestments (Current)
15.11M10.20M5.16M
Cash & Current Investments
40.98M37.70M32.38M31.63M26.15M23.67M23.71M21.94M18.38M29.64M26.39M21.87M18.14M14.51M11.11M10.69M10.69M8.88M5.20M4.12M
Receivables - NetNet Receivables
Receivables - OtherOther Receivables
0.11M0.20M0.61M0.08M0.28M0.36M0.36M0.54M0.42M0.47M3.78M0.08M1.15M-0.07M3.48M0.06M0.05M0.04M0.57M1.21M
Receivables
Prepaid Assets
3.63M2.55M2.18M3.16M4.16M3.91M2.23M2.86M4.59M3.50M2.45M2.26M2.46M0.83M1.31M1.31M2.32M1.18M1.07M1.74M
Current Assets
44.72M40.45M35.23M34.88M30.59M27.94M26.33M25.34M23.39M33.61M28.85M24.66M22.36M16.96M13.15M12.92M13.81M10.10M6.84M7.07M
Non-Current Assets
Property, Plant & Equipment (Net)PP&E (Net)
0.12M0.27M0.31M0.32M0.30M0.28M0.26M0.25M0.24M0.22M0.21M0.22M0.31M0.31M0.29M0.27M0.26M0.24M0.23M0.20M
Long-Term Investments
Intangibles
Goodwill & Intangibles
Other Non-Current Assets
Non-Current Assets
0.70M0.78M0.77M0.73M0.65M0.55M1.22M0.79M0.73M0.56M0.49M1.01M1.05M1.00M0.91M0.85M0.79M0.72M0.74M0.60M
Assets
45.42M41.24M36.00M35.61M31.23M28.49M27.55M26.13M24.13M34.16M29.34M25.67M23.41M17.96M14.07M13.77M14.60M10.82M7.58M7.67M
Liabilities
Current Liabilities
Accounts Payables
1.77M1.83M1.56M1.64M1.69M2.43M2.69M1.65M1.78M3.36M2.70M2.67M3.40M2.48M3.34M3.46M3.86M5.16M3.50M3.41M
Payables
1.77M1.83M1.56M1.64M1.69M2.43M2.69M1.65M1.78M3.36M2.70M2.67M3.40M2.48M3.34M3.46M3.86M5.16M3.50M3.41M
Accumulated Expenses
2.57M2.33M1.68M
Other Accumulated Expenses
-0.10M0.28M0.07M0.25M0.23M0.92M0.12M1.13M0.37M0.72M0.12M
Current Taxes
0.15M0.02M
Current Deferred Revenue
Total Current Liabilities
2.08M2.12M2.11M1.94M1.97M2.68M2.91M1.83M2.00M7.43M3.20M3.03M4.48M5.67M4.66M4.03M4.79M5.50M6.10M5.23M
Non-Current Liabilities
Non-Current Deffered Revenue
5.43M5.28M5.28M5.39M5.22M4.92M4.97M4.98M5.08M4.99M4.97M4.91M4.98M4.68M4.70M4.92M4.84M4.91M4.91M
Operating Leases
0.19M0.21M0.28M0.25M0.26M0.22M0.12M0.14M0.10M0.14M0.22M0.13M0.16M0.19M0.55M0.20M0.21M0.20M0.37M0.31M
Other Non-Current Liabilities
2.92M2.84M2.84M2.90M0.02M0.04M0.04M0.12M3.85M0.46M0.62M0.81M0.68M0.85M0.75M
Total Non-Current Liabilities
5.84M5.62M4.84M4.66M7.32M7.69M7.99M7.05M7.23M8.80M8.51M8.24M9.42M10.45M9.22M8.38M9.40M
Total Liabilities
7.92M7.75M7.67M7.56M7.35M7.72M7.99M7.08M7.34M12.65M8.51M8.70M10.04M11.26M9.90M9.23M10.15M10.74M11.38M13.84M
Shareholder's Equity
Common Equity
37.50M33.49M28.33M28.05M23.89M20.77M19.56M19.04M16.78M21.51M16.97M13.37M6.70M3.30M3.70M0.08M-3.80M-6.17M
Liabilities and Shareholders Equity
45.42M41.24M36.00M35.61M31.23M28.49M27.55M26.13M24.13M34.16M29.34M25.67M23.41M17.96M14.07M13.77M14.60M10.82M7.58M7.67M
Retained Earnings
-307.18M-302.39M-308.70M-320.61M-314.58M-299.61M-308.63M-314.07M-326.14M-327.67M-337.13M-334.59M-335.90M-347.70M-332.91M-338.53M-358.56M-362.86M-429.50M-448.18M

Oncolytics Biotech Balance Sheet API

Pull Oncolytics Biotech's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=ONCY&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY